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In this review paper, we discuss how the overarching concept of prehabilitation is applicable 
to alcohol dependence. Central to prehabilitation are the concepts of expected harm, risks, 
and proactive planning to eliminate the harm or cope with the risks. We review the evidence 
from animal models, psychological experimental studies, as well as pharmacological 
studies, on the potential risks and harms associated with medically assisted alcohol 
detoxification and the current treatment paradigm for alcohol dependence. Animal 
models provide an approximation mostly of the physical aspect of alcohol withdrawal and 
detoxification process and make predictions about the development of the phenomena 
in humans. Despite their limitations, these models provide good evidence that withdrawal 
from chronic ethanol use induces cognitive impairment, which is worsened by repeated 
bouts of withdrawal and that these impairments are dependent on the duration of 
alcohol withdrawal. Initial clinical observations with alcohol-dependent patients confirmed 
increased incidence of seizures. In recent years, accumulating evidence suggests that 
patients who have had repeated episodes of withdrawal also show changes in their 
affect, increased craving, as well as significant deterioration of cognitive abilities, when 
compared to patients with fewer withdrawals. Alcohol dependence is associated with 
tolerance and withdrawal, with neuroadaptations in γ-Aminobutyric Acid-A Receptor 
(GABA-A) and glutamatergic N-methyl-D-aspartate (NMDA) receptors playing key roles. 
It is suggested that dysregulation of the NMDA receptor system underpins alcohol-
related memory impairments. Finally, we discuss the Structured Preparation for Alcohol 
Detoxification (SPADe) as an example of how prehabilitation has been applied in clinical 
practice. We discuss the importance of partial control over drinking as an interim step 
toward abstinence and early introduction of lifestyle changes for both the patient and the 
immediate environment prior to detoxification and while the patient is still drinking.
Keywords: alcohol dependence, prehabilitation, withdrawal, detoxification, animal models, human research
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INTRODUCTION
The concept of pre-habilitation has been introduced in the field of 
orthopedics and describes a set of exercises and training routines 
for certain groups of patients with the aim to maximize physical 
strength and reduce the risk of expected harm or frequent injuries, 
therefore taking a proactive rather than a reactive approach. The 
concept is applied in surgery with the aim of preparing patients for 
a surgical intervention. It is a strategy for proactive management of 
risk factors associated with the surgical intervention. The approach 
is therefore described as a shift away from an impairment-driven 
reactive model and as an opportunity for introducing proactive 
sustainable and appropriate lifestyle changes (1).
Central to the successful implementation of pre-habilitation 
are the concepts of expected harm or risk and proactive planning. 
Both concepts are considered to be crucial determinants of the 
interaction between humans and the environment in general, 
associated with human evolution and the progress from hunting 
to agriculture, structured communities, and human civilization. 
Planning is crucial in all aspects of everyday life. The ability 
to predict or anticipate certain harm or assess certain risks is 
associated with the human ability of learning from experience, 
modify behavioral responses, and develop long-term and 
sustainable response strategies. To that effect, planning in 
advance of anticipation of risks can be considered as an essential 
strategy associated with individual survival and progress. 
Planning should not been viewed as a barrier for improvisation 
and innovation; on the contrary, it provides a stable environment 
for progress and positive change to take place.
The term “alcohol dependence” was first introduced in 
1976 (2) and was used in both International Classification of 
Diseases (ICD-10) classification systems (3) and the Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition 
(DSM-IV) (4). In DSM-5, dependence is now conceptualized on 
a continuum with abuse, such that a single disorder is now called 
alcohol use disorder (AUD) with mild, moderate, and severe sub-
classifications (5). Alcohol withdrawal syndrome is a collection of 
symptoms that occur after an alcohol-dependent individual stops 
consumption (6). Withdrawal from alcohol has been associated 
with cognitive impairments in recovering alcohol-dependent 
patients and furthermore the risk of relapse after withdrawal is 
associated with cognitive deficit (7, 8).
In this paper, we introduce the concept of pre-habilitation 
and its role in the clinical management of alcohol dependence. 
The approach has many aspects that overlap with other clinical 
management interventions, such as harm reduction and opioid 
substitution treatment. The overall aim is to reduce medical and 
other associated risks in a safe environment and to empower 
the individual to achieve the psychosocial changes required for 
recovery and social reintegration. Here, we focus on alcohol 
detoxification and withdrawal, given that it poses substantial 
risks to cognitive function. We review the evidence from animal 
studies, human psychological experimental studies, and imaging 
studies. We have conducted a narrative review of preclinical and 
clinical evidence regarding alcohol withdrawal or detoxification 
using online resources, e.g., PubMed and Google Scholar, and 
that were published in English prior to September 2018. For 
the preclinical evidence, we have focused the review on studies 
using cognitive behavioral paradigms rather than those on 
physical withdrawal symptoms, e.g., seizures. For the clinical 
review, we have focused on neuroimaging studies of relevant 
neurobiological processes.  We also discuss the limitations of 
current pharmacological interventions. Finally, we discuss, 
in some detail, an example of a clinical implementation of the 
model. In this paper, we have chosen to use the older and longer 
established term “patient” rather than client or service user. This 
choice does not refer to a scientific or philosophical position.
CURRENTLY RECOMMENDED 
TREATMENT PARADIGM TO MANAGE 
ALCOHOL DETOXIFICATION
Current clinical guidelines suggest that medically assisted 
withdrawal or detoxification is generally required for the treatment 
of moderate to severe alcohol dependence. This should be planned 
and the importance of providing structured aftercare is emphasized 
(9). Medically assisted detoxification is required to minimize the 
risks of withdrawal-related symptoms and complications.
The guidelines suggest that the patient prepares for 
detoxification by attending sessions at a specialist service to 
enhance and maintain motivation to change and develop a 
plan for structured aftercare (9). As described, the latter is 
considered important to ensure effective treatment. What 
is delivered however may vary widely with sessions not 
necessarily providing structured preparation to address issues 
such as stabilizing the amount of drinking, enhancing partial 
control over drinking, promoting early lifestyle changes, or 
empowering changes within the immediate family or social 
environment.
Detoxification may be medically assisted as an outpatient 
in the community or as an inpatient in a general hospital or 
a specialist unit. The choice between these two detoxification 
settings depends on health risk factors and the availability 
of social support to mitigate these risk factors during the 
detoxification process, and it is usually made by the health 
professionals (9). Medically assisted detoxification is discussed 
in more detail in Section 6 below.
Structured aftercare (also referred to as rehabilitation) 
is considered by clinical guidelines as the most important 
component of the current treatment paradigm, with strong 
evidence for its effectiveness (9). It is recommended that the 
structured aftercare that follows detoxification be delivered 
within a Cognitive Behavioral Therapy approach, either on an 
individual basis or via membership of a Relapse Prevention 
Group, alongside family interventions. It is highly recommended 
that patients engage with peer-support or mutual aid groups, such 
as Alcoholics Anonymous or SMART Recovery. Pharmacological 
interventions such as acamprosate, naltrexone, or disulfiram 
are also recommended. The existing evidence does not favor 
outpatient over inpatient detoxification, or residential aftercare 
treatment over community treatment, or longer versus shorter 
duration residential aftercare treatment programs (9). However, 
access to residential aftercare programs is recommended for 
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homeless individuals, and efforts should be made to address 
accommodation issues prior to discharge (9).
Two of the long-term challenges for professionals (both 
academics and clinicians) involved in the treatment of alcohol 
dependence are the definition of successful outcome as well as 
the high relapse rate. For example, statistics from Public Health 
England for the period 2017–2018 suggest that 61% of clients 
complete treatment successfully (i.e., are free from dependence, 
which could mean abstinence but not necessarily), the same 
proportion as the previous year (10). This number provides an 
indication of how successful treatment is but is dependent on 
the definition of successful treatment, the severity of presenting 
problem, and the time when completion and exit are reported. 
Other indicators such as maintenance of abstinence for 6 months 
and 12 months for alcohol-dependent patients could enhance 
our understanding of the effectiveness of the current treatment 
paradigm. Our local data suggest that only 60% of patients who 
have completed planned detoxification have been engaged in 
aftercare interventions, which are considered to be essential 
for long-term recovery (11). This ratio has improved to 82% 
when a pre-habilitation approach has been implemented, such 
as participation in the Abstinence Preparation Group (see 
Section 7 below) (12). There may be several explanations for this 
improvement, including benefits of participating in a group or 
more specific theory-based factors such as regaining of partial 
control over drinking and early lifestyle changes (12).
In summary, current treatment guidelines advocate 
avoidance of unplanned and urgent detoxifications as 
they do not lead to sustainable outcomes with regard to 
drinking behaviors (9). They put emphasis on the provision 
of psychological treatment following detoxification and 
promotion of participation in peer-support interventions (9). 
Given the challenges in improving treatment outcomes, we 
consider that the main shortfalls of these guidelines are that 
(1) the only therapeutic input prior to detoxification is restricted 
to motivation enhancement and preparation of an aftercare 
plan without any theory-based structured intervention to 
manage the risks expected once alcohol is withdrawn, and 
(2) a large proportion of patients completing detoxification 
do not engage with any evidence-based aftercare to reduce 
the risk for relapse. Given that the majority of psychological 
interventions may not have an immediate effect, and the high 
risk of relapse during the first 3 months post-detoxification, 
we need to consider an alternative approach such as pre-
habilitation to reduce the risk of relapse. Furthermore, the fact 
that these interventions are taking place during a period of 
mood dysregulation, which is the result of the detoxification 
itself, might compromise their effect.
LEARNING AND HABIT DEVELOPMENT 
IN HUMANS
Humans have the ability to test out a new behavior as a solution 
to a challenge and—depending on the results (e.g., reward)—
to either consolidate or abandon this behavior. Consolidated 
rewarding behaviors then become repeated in similar (or 
different) situations and, over time, become automatized. This 
leads to the fast replication of such behaviors—a bypassing of 
the conscious and careful consideration of pros and cons—
since the analysis of their efficacy has already been done, in 
the past, and proven successful (13). The ability to automatize 
successful behaviors allows humans to continue with further 
learning and the accumulation of new skills and expertise. 
This ability to bypass the conscious decision-making control 
mechanism confers the advantage of fast and successful 
responses to dangerous environmental stimuli, but it has 
a major disadvantage: humans are not able to monitor the 
appropriateness of the behavior or assess the possible need for 
behavioral modification (13).
Whenever an automatized behavior requires modification, 
the learning process must be slowed down, in order to allow 
for the decision-making process to again become conscious. 
This does not refer to a meta-cognitive process, but rather to 
the creation of time and space between the high-risk situation 
and the behavioral response. In other words, implicit cognitions 
must again become explicit if the individual is to regain 
conscious control in order to modify the extant behavior. It is 
easier to undertake this reversal process (14) in a safe, practice-
friendly environment, where those factors necessitating the 
fast reproduction of a behavioral response may be kept under 
control. Factors such as stress, threat, or uncomfortable physical 
symptoms typically provoke instinctive responses of a habitual 
nature. Humans tend to think more clearly and laterally when 
they can explore alternative solutions without facing immediate 
threat or being subject to stress.
The Expected Risk in Alcohol Dependence
In the case of drinking (as well as other substance misuse), 
this leads to the state whereby habitual drinking dominates 
all other behaviors and becomes repeated despite the person’s 
awareness of its loss of effectiveness and the accumulation of 
evidence of the associated harm. This leads the person into 
the paradox of wanting (implicit activation of need) although 
not liking (conscious desire and choice) drinking (15). From 
a psychological perspective, all explicit cognitions—such as 
positive and negative expectancies of the effect of drinking—
which were conscious and under the control of the individual, 
are rendered implicit, and bypass the conscious decision-
making pathway fuelling the continuation of drinking 
(13). This phenomenon is described as “loss of control”, 
an underlying theme common to 9 out of the 11 criteria of 
Alcohol Use Disorder in DSM-5 (5), three out of six criteria 
for alcohol dependence in ICD 10 (3), and one of three in 
ICD 11.
In the sections below, we discuss the risks associated with 
alcohol withdrawal and medication-assisted detoxification 
interventions. We review the evidence from animal models, 
pharmacological studies, and psychological experimental studies 
to explore risks such as cognitive impairment, stress sensitivity, 
the limitations of medication-based protective roles, as well 
as limitations of the existing treatment paradigm of planned 
detoxification and rehabilitation.
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ANIMAL MODELS OF ALCOHOL 
WITHDRAWAL AND DETOXIFICATION 
ON COGNITIVE IMPACT
Animal models have been used to try and understand the 
phenomenon of alcohol withdrawal and specifically to determine 
if repeated withdrawals particularly have an impact on cognitive 
function. Animal models have several advantages in alcohol 
research. They may be used to study determinants of alcohol-
related behavior where there are ethical issues with carrying 
out such research in humans due to risks in giving volunteers or 
patients addictive harmful substances (16).
Further, animal models are used because animals have similar 
genetic, biochemical, and physiological compositions to humans. 
Therefore, research using animals can inform the understanding 
of the human condition and help lead to the development of 
new therapeutics. Some of the current medications approved 
for the treatment of alcohol use disorders (e.g., naltrexone 
and acamprosate) were developed using animal models (16). 
However, animal models do not represent the entire complex 
disorder; instead, they allow the study of component features of 
the condition and help provide evidence for the determinants of 
such behaviors (17).
There are currently several different methods used to 
model ethanol (alcohol) dependence in rodents such as forced 
consumption in drinking water, ethanol containing liquid 
diet, ethanol vapor inhalation, and repeated intraperitoneal 
or intragastric administration (18). In addition to route of 
administration, the length of ethanol exposure varies between 
models of alcohol use, e.g., from a 4-day chronic intermittent 
exposure (19) or a 6-month chronic model (20). The variation 
in both administration and duration of chronic ethanol 
administration complicates the interpretation of results. All of 
these models aim to mimic the neuroadaptations in the brain, 
which lead to tolerance and physical dependence of alcohol. A 
key issue with these models is the forced exposure to ethanol, 
which doesn’t accurately represent the compulsive element of 
the human experience of alcohol dependency despite efforts 
to assess operant re-enforcing and conditioned responses (16). 
Induction of alcohol dependency in animals is considered to be 
successful if withdrawal symptoms are present upon cessation of 
exposure (18). However, this is representative only of a physical 
dependency and lacks the complexity of all the environmental 
and psychosocial influences that contribute to the complex 
human experience of alcohol addiction.
Animal models of alcohol consumption have also been 
developed to reflect voluntary alcohol consumption such as the 
two-bottle choice test, using gradually increasing concentrations 
of ethanol or adding sweeteners (17). Although preference 
tests are often influenced mainly by taste, some animals show a 
preference for the pharmacological effects of alcohol, and this 
has allowed genetic manipulation to produce high or low alcohol 
preference breeds. Rodents will voluntarily consume up to 40% 
ethanol (16). For the study of alcohol withdrawal, these voluntary 
consumption paradigms are often not sufficient because 
consumption levels are not high enough to induce withdrawal 
symptoms. Another limitation of these procedures is the 
difficultly to determine an animal’s motivation to seek alcohol. 
Motivation to consume alcohol can be best demonstrated by an 
operant task model (such as lever pressing to receive alcohol in 
which the number of presses required increases) or a conditioned 
place preference task [for a detailed description, see (21)].
The Impact of Withdrawal on Cognition
Physical withdrawal symptoms are similar in humans and 
animals and include tremors, agitation, rigidity, spontaneous 
seizures, audio sensitivity, handling-induced seizure sensitivity, 
and weight loss (22). However, alcohol withdrawal induces much 
more than just physical symptoms with low mood and anxiety 
evident. This negative affective state is thought to contribute 
to the risk of relapse in alcohol dependence and is therefore a 
critical area of study (these effects in humans are discussed in 
detail in Section 5 below). Withdrawal is thought to induce these 
effects via neuroadaptations from chronic ethanol’s exposure 
on brain areas that control fear and memory. For this review, 
we focused on the studies assessing the impact on withdrawal 
from chronic alcohol exposure on cognitive function in rodents, 
which are summarized in Table 1. This table shows evidence that 
cognitive deficits are seen in animal models of withdrawal, that this 
deficit can worsen with repeated withdrawal, and finally that this 
cognitive impact varies with the length of the withdrawal period.
The Presence of Cognitive Impact
The experiments in Table 1 used behavioral paradigms following 
a variety of chronic alcohol models to assess cognitive function 
including the elevated plus maze, the T maze, social interaction, 
and conditioned fear response learning. These have been used 
to demonstrate withdrawal-induced impairments in learning 
(19, 31), cognitive flexibility (26), memory (20, 24, 25, 31, 
36), sociability (38), as well as increasing anxiety (23, 27) and 
sleep disruption (35). In addition to the previously described 
limitations associated with animal models of chronic alcohol 
consumption and withdrawal, these studies are also subject to 
the limitations of the behavioral paradigms used. For example, 
several studies that illustrate the effect of ethanol withdrawal on 
inducing anxiety in rodents use paradigms such as the elevated 
plus maze, the light–dark box, and the open field (18). Measures 
used in these paradigms such as line crossings or % of time spent 
in the center, can be influenced by impaired locomotion of the 
animal, as well as anxiety, and therefore these results may lack 
construct validity. However, taken together, given the multiple 
cognitive defects assessed, it can be concluded that alcohol 
withdrawal may induce some cognitive impairment.
The Effect of Multiple Withdrawals
Several of the studies described in Table 1 indicate the worsening 
of withdrawal symptoms given multiple withdrawal episodes, 
which is consistent with the clinical picture. The best documented 
example of this phenomenon in rodents is the frequency of 
seizures following several detoxifications: known as the kindling 
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effect (39, 40). The kindling effect is defined by Pinel et al. as “the 
progressive intensification of elicited motor seizures that occurs 
during a series of convulsive stimulations”; this leads to increased 
susceptibility to convulsive seizures during alcohol withdrawal 
due to previous seizure-inducing withdrawals (39). The impact 
of multiple withdrawals also has a worsening effect on some of 
the associated cognitive impairments. This was demonstrated 
using rats fed an ethanol-containing diet (13–14 g/kg/day) for 
24 days with two 3-day withdrawals compared with controls and 
with rats undergoing continuous ethanol treatment (23). These 
rats performed worse at negative patterning tasks but not spatial 
learning, which indicates that repeated withdrawals may affect 
some areas of cognition such as plasticity but not others. This 
differential effect of repeated withdrawals on only some cognitive 
defects is consistent with evidence that repeated withdrawals 
in rats compromised the acquisition of a conditioned fear 
response without impacting the recall of a previously learned 
fear association (29). These findings led to a hypothesis that 
multiple withdrawals induce aberrant neuronal plasticity, which 
gives rise to interesting predictions. Based on the idea that 
repeated withdrawal from alcohol results in repeated overactivity 
within glutamatergic systems (see below), it is possible that 
hyperactivation of glutamatergic systems would induce synaptic 
plasticity, leading to synaptic strength. If repeated withdrawals 
increase synaptic strengths, then stimulation of input pathways 
will have an enhanced effects on outputs, leading to certain 
excitability. However, if synapses are already strengthened, then 
the capacity for further plasticity will be reduced, leading to 
impaired learning of new associations (41, 42). However, further 
research is required to determine the underlying mechanism(s) 
behind multiple withdrawals reinforcing some but not all 
cognitive defects.
The Duration of the Withdrawal Effect 
on Cognition
A key consideration is the duration of withdrawal from alcohol 
treatment. Some studies have looked at immediate effects of 
withdrawal after 8–24 h (23, 36, 37), while others assess cognitive 
defects present after a much longer period (several weeks) (25, 
31). One key question is whether any cognitive impairment is 
long-lasting and/or persistent even following a significant period 
of abstinence. One study found that withdrawal caused significant 
working memory impairment during acute withdrawal (24–72 h) 
but not extended abstinence (16–68 days) (36). This contrasts 
with another study in mice in which short-term memory was 
not affected by withdrawal but learning and long-term memory 
were still impaired when tested 12 weeks after cessation of 
ethanol consumption (31). This suggests that withdrawal, while 
having a severe acute effect on cognition, may also cause long-
lasting impairments. Therefore, the type of cognitive impairment 
present may also differ depending on the duration of abstinence.
Proposed Mechanisms of Withdrawal-Induced 
Cognitive Dysfunction
There is much discussion about the mechanism by which 
withdrawal from chronic ethanol induces cognitive impairments. TA
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Animal models have been used to link alcohol consumption 
with neurodegeneration and changing brain structure by 
neurotoxicity, reducing neurogenesis, and reducing the size of 
existing neurons. This has been related to dysfunctional behavior, 
which is suggestive of cognitive impairments (19). There have 
been several studies investigating the processes underlying 
these neurotoxicities. One such experiment in both rats and 
mice of both genders found increased levels of corticosterone 
in the brain tissue and plasma of both acutely (plasma) and 
prolonged (brain) withdrawn animals (43). Raised levels of 
corticosterone are known to cause neuronal damage, and it 
was therefore proposed as a potential mechanism underlying 
withdrawal-induced cognitive dysfunction. These raised 
corticosterone levels are thought to increase neuronal damage 
by potentiating excitatory transmission, inducing neuronal 
atrophy. Additionally, increased expression of NMDA receptors 
was found on the synaptic neurones of the medial prefrontal 
cortex, using a mouse model of chronic intermittent ethanol 
(26). This was also linked to a behavioral deficit in cognitive 
flexibility a week after the cessation of ethanol consumption. 
These findings suggest that the neuro-adaptive changes as 
a result of chronic alcohol consumption may contribute to 
withdrawal-induced dysfunction.
Other studies have focused on which brain areas are 
damaged during alcohol withdrawal, which may further inform 
how cognitive defects occur. For example, rat performance on a 
cognitive task was impaired by lesions of the basolateral amygdala 
(conditioned reinforcement and reinforcer devaluation) and 
central nucleus of the amygdala (Pavlovian-to-instrumental 
transfer) to identify which area is affected during single or 
repeated withdrawals. The result indicated that the central 
but not basolateral nucleus was affected during withdrawal. 
Similarity studies of mouse brains found that dendritic spine 
density was reduced in the lateral orbitofrontal cortex of mice 
following chronic intermittent exposure to ethanol (43). A 
comprehensive review of all relevant research is beyond the 
scope of this article; however, these examples provide evidence 
that the induction cognitive dysfunction following withdrawal 
is a complex process involving several brain regions. It is a vital 
area of research if we are to protect the brain, or at least limit the 
damage, in alcohol dependence.
Conclusion From Animal Models
Ultimately, there are several different animal models of chronic 
alcohol consumption that are used to study the impact of 
withdrawal on cognition. While these models fail to replicate 
all the complexities of psychosocial and compulsive factors that 
occur in the human experience of withdrawal, these animal 
models provide good evidence that withdrawal from chronic 
ethanol induces cognitive impairment, that this impairment 
is worsened by repeated bouts of withdrawal, and that these 
impairments are dependent on the duration of alcohol 
withdrawal and abstinence. These animal models have led to 
the identification of neuroadaptations and increased levels 
of corticosterone as potential modifiers of cognitive deficits 
caused by withdrawal and which brain regions are vulnerable 
to or involved in these impairments. Understanding the risks 
of withdrawal and the underlying neurobiology is vital if we are 
to develop more effective therapies for reducing the damaging 
consequences of alcohol withdrawal.
CONSEQUENCES OF REPEATED 
DETOXIFICATION OF PATIENTS 
DEPENDENT ON ALCOHOL
There is strong evidence that repeated detoxifications are 
associated with several cognitive and emotional impairments. 
Initial observations confirmed increased incidence of seizures 
(44–46). During recent years, accumulating evidence suggests 
that individuals who have experienced repeated episodes of 
withdrawal show changes to their affect, increased craving, as 
well as significant deterioration of cognitive abilities, when they 
are compared to patients with fewer withdrawals (47–49).
Several investigators had suggested that repeated episodes of 
detoxification increase the risk of withdrawal seizures. Further 
support to their suggestion came with the discovery of the 
differential response of alcohol-dependent patients to anxiety 
evoked by the noradrenergic alpha2 agonist, yohimbine, between 
those with two or more detoxifications compared to those 
with only one (50). These initial observations were followed 
by a plethora of experimental evidence showing that repeated 
experience of repeated detoxifications results not only in 
increased incidence of seizures and anxiety but also in increased 
craving and impaired inhibitory control of several behaviors in 
tasks (50, and in more detail below, e.g., 51, 52). Such tasks are 
challenging for high-order executive functions within problem 
solving or emotional evaluation contexts like reward seeking 
under conditions of incentive conflict, cognitive flexibility in an 
intra-extra dimensional shift, and reversal task and recognition 
of emotions in others.
Correspondingly, brain imaging shows that inaccurate 
performance on the cognitive tasks in alcohol dependence 
in humans who had experienced multiple detoxifications is 
associated with loss of gray matter in prefrontal regions; the 
loss of gray matter is positively correlated with the number of 
detoxifications. Evidence also suggests that the ability to recognize 
emotions in others (e.g., fearful faces) is associated with reduced 
connectivity between insula and prefrontal areas, but increased 
connectivity between insula and subcortical regions (colliculus) 
and between amygdala and other subcortical regions [e.g., bed 
nucleus of stria terminalis (BNST)].
Understanding the mechanisms that underlie the 
associations between repeated detoxifications and cognitive 
and emotional impairments as well as brain structure and 
functions alterations is mainly based on animal models 
[see previous section and (23)]. Additionally though, binge 
drinking (a tendency to drink excessively in one session 
leading to intoxication followed by abstinence) in young 
human adults has also been used as a model to explore possible 
predisposition to and early consequences of alcohol drinking 
in the form of repeated cycles (53–58).
Here, we will summarize the empirical evidence of the 
cognitive and behavioral deficits and their brain substrates 
Prehabilitation in Alcohol DependenceKouimtsidis et al.
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associated with repeated detoxifications and how such deficits 
may increase vulnerability to relapse.
Cognitive Control Processes Involved 
in Relapse
Increased urges to drink alcohol when induced by alcohol-
associated stimuli and reduced ability to control the amount are 
recognized as the two basic processes of alcohol dependence. 
Inhibitory control is necessary for self-regulation. This is linked 
to executive function. Individuals who have low executive 
capacity or have damage to brain substrates subserving executive 
function display reduced ability for self-regulation and a greater 
susceptibility to behavior driven by stimulus and relapse (59, 
60). Stimuli irrelevant to the present task or in contrast to the 
individual’s current goals can diminish self-regulatory behavior 
in a stimulus-driven fashion and lead to relapse (61, 62). Other 
evidence, however, suggests that a stimulus-driven effect may 
be dependent on search goals driven by the individual’s desire 
to consume alcohol (63). Several cognitive processes are 
considered to support self-regulation such as working memory 
and the ability to shift attention from previously relevant (but 
now irrelevant) stimuli (e.g., alcohol cues) to currently relevant 
factors (e.g., awareness of drinking consequences).
With the escalation of dependence, alcohol-associated 
stimuli become more salient and attract attention faster, thus 
diminishing the ability to inhibit the urge to drink. Such alcohol-
associated attentional bias predicts relapse rates and treatment 
outcomes (64). Neuroimaging studies have provided strong 
evidence for the increased involvement of stimulus-driven 
networks (subcortical structures) and reduced involvement 
of brain substrates associated with cognitive control (65–67). 
Thus, as dependence progresses, relapse after several efforts to 
achieve and maintain abstinence becomes increasingly likely as 
distinct places, people, and paraphernalia associated with the 
reward offered by alcohol trigger an intense motivation within 
the addicted person to consume alcohol. As mentioned above, 
attentional processes (i.e., the ability to shift attention from 
previously relevant (but now irrelevant) stimuli to currently 
relevant factors may be crucial for self-regulation. Although 
impairments of cognitive control are associated with increased 
incidence of relapse in alcohol dependence, few studies have 
directly examined the possible impact of repeated detoxifications 
on cognitive control.
Alcohol-dependent individuals show impaired cognitive 
flexibility as measured in an intra–extra dimensional shift and 
reversal task (IED). This is associated with reduced volume of 
gray matter in a cluster within the inferior frontal gyrus (BA47) 
and the neighboring anterior insula. This is an area that shows 
reduced gray matter volume in alcohol-dependent patients and 
especially in those with a history of multiple detoxifications 
(52). The inferior frontal gyrus (IFG) is an area involved in 
inhibitory control. Observed decreased gray matter volume in 
this area suggests that decreased inhibitory control due to IFG 
damage may be linked with repeated relapses (68). Therefore, 
inhibitory control seems to modulate the translation of desire 
to drink into alcohol consumption and weakening of inhibitory 
control may lead to addiction (68). To that effect, strengthening 
inhibitory control may be an important cognitive strategy to 
prevent relapse (69).
Social Competence as a Cause of Relapse: 
Brain Mechanisms
The cognitive deficits caused by reduced function of prefrontal 
brain areas (41, 42) in alcohol dependence, arising from repeated 
detoxifications, may not only contribute to inflexible behavior 
and perseveration of drinking but also to the impairments in 
social cognition, which is crucial for adaptive social interaction 
(70, 71).
Earlier studies have demonstrated that alcohol-dependent 
patients generally have reduced ability to recognize emotions 
expressed by facial expression in others (72–74). Our research has 
shown that such impairments may increase with greater numbers 
of detoxifications (75). Emotional recognition deficits are 
associated with less successful recovery (76, 77). A recent study 
that examined prospectively objective treatment outcomes found 
that alcohol-dependent patients who were poor in recognizing 
emotions in others were also more prone to relapse (78).
Neuroimaging findings have revealed brain changes associated 
with emotion recognition deficits most commonly in prefrontal 
cortex, amygdala, and insula brain areas (51, 52). The amygdala is 
the brain structure involved in processing of emotion (79) including 
the recognition of fearful facial expressions (80); the insula is 
associated not only with emotional processing but also with emotion 
regulation. Imaging the brain of alcohol-dependent patients during 
fear recognition in emotional facial expression of fear (74) revealed 
reduced connectivity between insula and prefrontal emotional 
regulatory regions (81–84). In particular, a reduced connectivity 
of insula with the anterior cingulate cortex (ACC), orbitofrontal 
cortex (OFC), and ventrolateral prefrontal cortex (VLPFC) was 
seen in alcohol-dependent patients with two or more detoxifications 
compared with either controls or patients with a single or no prior 
detoxification (51). Increased connectivity, also in patients with two 
or more detoxifications, was found between insula and a colliculus 
neuronal cluster, a region representing an important subcortical area 
for arousal mechanisms (85), as well as between amygdala and bed 
nucleus of stria terminalis (BNST). BNST has been identified as the 
key component area of stress-induced relapse in animal models of 
addiction (86). From these findings, it can be argued that increased 
connectivity in amygdala-related networks could lead to an increased 
emotional reactivity (84), whereas decreases in the network integrity 
of insula-related networks could lead to inappropriate analysis of the 
emotional input (87).
Importantly, the strength of connectivity between insula and 
areas involved in control of behavior and regulation of emotion 
(inferior frontal cortex, frontal pole) was negatively correlated 
with the number of detoxifications and with the ability to control 
drinking as evaluated by a self-rating questionnaire (ICQ; 51), 
suggesting a relationship between repeated detoxifications and 
the subjective perception of the ability to abstain. These findings 
further support that focusing treatment in reducing the impact 
of repeated experiences of detoxifications represents a reasonable 
approach.
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Incentive Conflict and Cognitive Control 
as a Cause of Relapse: Brain Mechanisms
From the above, it becomes clear that controlling drug taking 
depends on the ability of higher-level monitoring functions to 
interrupt the incentive process that is induced by the rewarding 
properties of the drug, but could also depend on the strengthening 
of the incentive process as addiction progresses (88).
Drug taking is considered as an impulsive choice for an 
immediate positive outcome based on previous hedonic experience 
or relief from pain or stress but on the possible expense of long-
term health and social benefits. Alcohol dependence may impair 
processes that contribute to choice impulsivity (89), so that later 
consequences of drinking are not taken into account. For the 
alcohol-dependent patient trying for abstinence, the conflict 
between the desire to drink and the aim to abstain in order to 
avoid adverse consequences may be particularly strong, leading to 
erroneous choice at the time and a lapse.
We have studied aspects of the interaction between incentive 
learning and behavioral control using the incentive conflict task 
(ICT) (90). This is a version of negative patterning tasks used in 
cognitive psychology (91). When performing the ICT, subjects 
first learn that two independent discrete cues signal reward 
(money gains), and in this way, they acquire incentive properties. 
In a second phase, while the individual cues continue to signal 
reward, when presented together in a compound, they signal 
punishment (money losses). Participants have to learn to respond 
appropriately so that they respond to gain money when the 
stimuli are individually presented, but withhold responding to 
avoid money losses when the stimuli are presented in compound. 
The incentive conflict task is thus a task that puts demands on 
decision-making under conditions requiring conflict resolution. 
We have proposed that the task creates a conflict between 
abstaining and responding for reward, which is similar to that 
experienced by the patient before lapse. Therefore, the impaired 
ability of patients who have experienced multiple detoxifications 
to perform the task might reflect the consequences of the 
detoxification process itself on behavioral control.
As the number of previously experienced detoxifications 
increases, patients become increasingly impaired in withholding 
their responses in the condition of no reward, suggesting that 
the process of detoxification may engender brain changes that 
affect decision-making to avoid reward losses and lead to loss of 
control (90). This is consistent with deficits observed in a rodent 
version of the same task, in rats chronically exposed to alcohol 
(23). Importantly, in this well-controlled animal study, it was the 
number of withdrawal events (“detoxifications”) that determined 
the extent of the deficit.
Neuroimaging of the ICT task with human control participants 
shows activation of several areas but most importantly those of 
the supplementary motor area, striatum (including putamen), 
gyrus rectus, ventromedial prefrontal cortex (vmPFC), and 
superior frontal gyrus areas, which are implicated in cognitive 
and emotional processing of reward (91–93) and regulatory 
control over a behavioral response (94, 95). Smaller gray matter 
volume in alcohol-dependent patients in the areas where 
dysregulated brain responses are seen during ICT have been 
reported, such as vmPFC and superior frontal gyrus, even more 
so in patients who had experienced more detoxifications. This is 
consistent with suggestions that these smaller volumes are “brain 
damage” associated with the detoxification experience. Further, 
the smaller volumes likely are associated with impairments 
in motivational decision-making, which involves the vmPFC 
(96, 97), and behavioral control, which involves the superior 
frontal gyrus (94, 95). Activation changes of vmPFC is shared 
with the gambling task (97), which resembles incentive conflict 
in requiring decision-making. Alcohol-dependent patients 
with several detoxifications also show impairments in this task 
(98). These findings are further supported by a study (99) that 
found that resolution of emotional conflict was associated with 
activation of an area that included the vmPFC.
Blunted response of the vmPFC in alcohol-dependent humans 
to the presentation of stress cues, a condition that the ICT also 
possibly generates, has been found to predict the incidence of 
relapse (100). Higher incidence of relapse with the possibility 
of trying to detoxify again leads to experience of multiple 
detoxifications found in our studies to be associated with smaller 
gray matter volume in vmPFC. Aberrant responsiveness to vmPFC 
to stress (101) is proposed to be associated with autonomic neural 
system dysfunction probably induced by the decreased ability 
of vmPFC to regulate emotional responses to stress or conflict 
situations. Prefrontal gyrus activation on the other hand may 
be more associated with the attentional and executive processes 
involved in inhibitory control that govern responding to ICT (94, 
95, 102). Recent work on brain network efficiency of patients with 
alcohol dependence has identified, among other areas, the superior 
frontal gyrus area to show reduced nodal efficiency, supporting 
reduced ability of this area to carry out its functional activity (103).
The damage induced by alcohol—and detoxification—is 
not restricted to the areas identified in the ICT experiments. 
For example, the inferior frontal gyrus has been implicated in 
previous research during cognitive set switching (104) and also 
when resolving decision conflict during an instrumental learning 
task (105). Again, decreased inhibitory control due to IFG 
damage may support the occurrence of repeated relapses.
BRAIN IMAGING OF ALCOHOL 
DETOXIFICATION IN HUMANS
Alcohol dependence is associated with tolerance and withdrawal 
with neuroadaptations in GABA-A and glutamatergic N-methyl-
D-aspartate (NMDA) receptors playing key roles (106). 
Dysregulation of the NMDA receptor system is thought to 
underpin alcohol-related memory impairments (107).
Imaging Glutamate in Humans
In humans, magnetic resonance spectroscopy (MRS) can be 
used to measure glutamate levels in the brain, albeit often with 
other metabolites and neurotransmitter and metabolic pools 
that cannot be robustly distinguished (108). A number of studies 
have reported greater glutamate levels in alcohol-dependent 
individuals during early withdrawal from alcohol.
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One study reported greater MRS glutamate + glutamine 
(Glx) levels in the anterior cingulate cortex (ACC) at the 
start (day 1) of alcohol detoxification in alcohol-dependent 
individuals compared with controls, which normalized over the 
next 14 days (109). Benzodiazepines were used for treatment. 
Glx levels were not related to severity of alcohol withdrawal. 
Complementary preclinical translational studies showed that 
glutamate levels in the medial prefrontal cortex (mPFC) of 
ethanol-dependent rats were increased at 12  h of withdrawal 
compared with controls and during intoxication; the glutamate 
levels had declined by 60  h. A further study from the same 
group provided more evidence that a hyperglutamatergic state 
is associated with brain neurotoxicity. In both humans and rats, 
hippocampal glutamatergic function was found to be inversely 
related to volume, although notably, no differences were found 
with controls in either species (110). This may have been due 
to different methodology and lack of power to detect a group 
difference due to smaller hippocampal volume.
However, other studies have reported that human glutamate 
levels were lower in the ACC, dorsolateral prefrontal cortex 
(DLPFC), or parieto-occipital cortex (POC) 9 days after 
stopping drinking compared with “light drinkers” and 
normalized (i.e., increased) during the following month in 
ACC only (109). The authors suggested that their first time 
point may have missed the early elevation in glutamate 
reported by others and that, altogether, studies suggest that 
glutamate levels change during alcohol withdrawal and early 
abstinence. Although glutamate levels at the earlier time point 
were inversely associated with cognitive task performance, 
improved cognitive function was not related to any 
changes in glutamate or indeed other MRS markers [creatine, 
N-acetylaspartate (NAA), choline, and GABA]. Similarly, 
lower glutamine levels have been found in alcohol-dependent 
individuals who are still drinking, though breathalyzed 
negative at the time of the scan, compared with light drinkers 
(111). An inverse relationship between glutamate, but not 
glutamine, levels and number of heavy drinking days has been 
reported in ACC of alcohol-dependent participants but not 
light drinkers (18).
Higher levels of glutamate + glutamine in the nucleus 
accumbens and anterior cingulate have also been shown to 
be positively related to craving in recently detoxified alcohol-
dependent individuals (112, 113). However higher levels have 
not always been reported in the anterior cingulate (112), which 
may suggest a differential rate of glutamatergic normalization 
in brain regions. No moderating effect of medication, e.g., 
diazepam or clomethiazole, was seen on glutamate levels and 
no relationship was seen with withdrawal symptoms (112). No 
cognitive measures were described in this study.
Although studies did not necessarily find any relationship 
of glutamate levels with clinical variables, this is likely due to 
the clinical heterogeneity of alcoholism in the small number 
of participants in these imaging studies. Due to the lack of 
appropriate longitudinal studies, it is not clear whether any 
differences in MRS-derived markers reflect the neurotoxicity 
or neuroadaptations from alcohol directly or predate alcohol 
consumption and increase the risk of an alcohol use disorder.
Modulating Glutamatergic Function
In human alcohol-dependent individuals undergoing alcohol 
detoxification, those who received acamprosate compared 
with placebo resulted in a reduction in a glutamate:creatinine 
ratio between 4 and 25 days in the anterior cingulate (114). 
Diazepam was allowed if required during detoxification. It 
appears that any effect of acamprosate took a while to develop as 
it did not have an effect on alcohol withdrawal symptoms or on 
glutamate:creatinine ratio in the first few days of detox. Another 
study reported that glutamate levels were reduced after 4 weeks 
of acamprosate treatment compared with slight increases in those 
patients who did not receive acamprosate (113). The evidence 
from these studies is consistent with acamprosate having an 
“anti-glutamatergic” effect and that this likely underpins its 
clinical efficacy including reduction in craving. As no cognitive 
measures were obtained in the participants in either study, it is 
unclear if acamprosate did result in any cognitive benefits.
Other MRS Markers
Other MRS markers of neuronal integrity and function have 
also been studied in alcohol use disorder. For example, evidence 
is not consistent with lower, higher, or no differences seen in 
the metabolite N-acetylaspartate (NAA), which is seen as a 
marker of neuronal integrity and function. This likely reflects 
the heterogeneity of the disorder and methodologies used. 
Nevertheless, there is evidence that NAA is lower as a result 
of heavy alcohol consumption, that it increases on stopping 
drinking, suggesting recovery, and that low thalamic NAA 
levels have been shown to be associated with poorer treatment 
outcomes at 3 months (115, 116).
Imaging Inflammatory Response 
in Alcoholism
The inflammatory burden of alcohol consumption and 
dependence in regard to cognition is not well characterized in 
humans though it is likely to be an important target for treatment 
(115). Such inflammation may also contribute to alcoholism, 
increasing the risk of Alzheimer’s disease (117). Positron emission 
tomography (PET) imaging studies assessing microglial activity 
with translocator protein (TSPO) tracers have shown lower, 
rather than higher, availability in abstinent alcoholics (106, 118, 
119). Indeed one study showed that TSPO binding was positively 
correlated with verbal memory performance (118). Therefore, 
these studies suggest that lower glial density or an altered 
activation state with lower TSPO expression may contribute to 
cognitive impairment in alcoholism.
Treatment of Alcohol Withdrawal/
Detoxification
As described, alcohol withdrawal and its complications develop 
as alcohol levels decrease and recurrent withdrawals result in 
increase in severity of symptoms due to kindling (120, 121). Such 
complications are also more likely in those alcohol-dependent 
patients who are hypoglycemic, hypokalemic, hypomagnesemic, 
or with infection or trauma (e.g., subdural hematoma) (120). 
Prehabilitation in Alcohol DependenceKouimtsidis et al.
12 May 2019 | Volume 10 | Article 339Frontiers in Psychiatry | www.frontiersin.org
Treatment of alcohol withdrawal generally attenuates the risk 
of such consequences, but too frequently, alcohol dependence 
is missed due to lack of appropriate questioning or disclosure, 
so appropriate treatment is not started. Clearly, since delirium 
tremens and seizures reflect brain toxicity, there may also be 
an effect on cognition; thus, their prevention is paramount 
to protect brain function and optimize recovery. The reader is 
directed to clinical guidelines concerning more information 
regarding treatment of alcohol detoxification and prevention of 
complications (9, 122, 123).
Medically assisted alcohol withdrawal is generally treated with 
a reducing regimen of a benzodiazepine (e.g., chlordiazepoxide, 
diazepam, and lorazepam) (120, 122, 123). An alternative regimen 
is “symptom-triggered”, where the benzodiazepine is given once 
symptoms meet a threshold for treatment. This requires regular 
monitoring of alcohol withdrawal symptoms with a validated 
scale [e.g., Clinical Institute Withdrawal Assessment for Alcohol 
(CIWA-Ar)] by appropriately trained staff and so is not suitable 
in all circumstances, e.g., a busy admissions unit or nonverbal 
patients. Other anticonvulsants may be used (e.g., carbamazepine 
and sodium valproate); however, a Cochrane review did not find 
evidence in favor of their use to treat alcohol withdrawal (124). 
It should be remembered that benzodiazepines are also effective 
anticonvulsants and therefore risk of alcohol-related seizures can 
be managed with sufficient doses rather than adding in another 
anticonvulsant (123).
Another important clinical intervention to reduce risk of brain 
toxicity is consideration of thiamine deficiency as this vitamin is 
a key co-factor in metabolism. Thiamine deficiency may present 
with “paresthesia” (pins and needles) in hands and feet with 
numbness and with Wernicke’s encephalopathy (WE), which 
is a medical emergency. Clinicians are advised to be suspicious 
as the classic triad of confusion, ataxia, and ophthalmoplegia, 
suggesting the diagnosis of WE, are rarely seen together, whereas 
the first two symptoms are very commonly seen in alcoholism 
(123, 125). Clinically, thiamine deficiency and WE are generally 
only considered with alcohol detoxification when greater 
metabolic load increases the risk; however, it may occur at any 
time and in other addictions with poor diet and absorption. For 
those with WE or at risk of it, parenteral thiamine is required 
since absorption from oral thiamine is insufficient to replenish 
stores (122, 123, 125). Thus, giving thiamine appropriately is 
a critical intervention to protect brain function and prevent 
irreversible alcohol brain-related brain disorder.
As described, current clinical treatment with benzodiazepines 
may not be optimal in attenuating the hyperglutamatergic state of 
alcohol withdrawal. As described, MRS studies have shown that 
acamprosate reduces glutamate in the brain. Clinically, acamprosate 
appears to be well tolerated during alcohol detoxification, when 
added to benzodiazepines, though there is no impact on alcohol 
withdrawal symptoms as measured with the CIWA-Ar (114, 126). 
However, acamprosate during alcohol detoxification has been noted 
to improve sleep and reduce arousal levels (alpha slow-wave index) 
when assessed with magnetoencephalography (127). Therefore, it is 
unclear if acamprosate-related reduction in glutamatergic activity 
does improve cognitive outcomes either in the short term or in the 
longer term.
EXAMPLES OF IMPLEMENTATION 
OF PRE-HABILITATION IN ALCOHOL 
DEPENDENCE
As described, the concept of pre-habilitation can be applied to the 
treatment of alcohol dependence, such as our model: “Structured 
Preparation for Alcohol Detoxification” (SPADe). Although SPADe 
has been applied on an individual basis, primarily it has been 
applied as an open, rolling group program, and described initially 
as Preparation for Alcohol Detox (PAD) and more recently as 
Abstinence Preparation Group (APG). The intervention may be 
regarded as a modified Cognitive Behavioral Therapy approach 
(128, 129), which is offered prior to detoxification and while the 
person is still drinking. The basic components of this treatment 
approach include (i) partial control over drinking, (ii) introduction 
of lifestyle changes for the individual, (iii) and the immediate family 
and social environment. Existing evaluations of SPADe treatment 
pathways suggest that about 72% of individuals with alcohol 
dependence presenting for treatment can engage and complete the 
pre-habilitation intervention (APG) (12).
Partial Controlled Drinking
When presented as an alternative to lifelong abstinence as the 
sole treatment outcome (130), the concept of controlled drinking 
generates intense conflict within the field of addiction medicine. 
However, within clinical guidelines (9) controlled drinking 
within “healthy” limits may be considered as an appropriate 
treatment objective for harmful drinkers. For dependent drinkers, 
abstinence remains the preferred treatment objective (9).
The main aim of pre-habilitation is to pre-empt clinical 
withdrawal symptoms and the associated urges to drink. Within 
the SPADe treatment approach for alcohol dependence, controlled 
drinking is referred to as “partial” for two reasons: (i) it is an 
intermediate treatment stage rather than the final treatment aim, 
which is abstinence; and (ii) the amount and pattern of drinking 
are not within healthy limits. Therefore, within SPADe, the primary 
aim of the “partial controlled drinking” stage is to stabilize both the 
amount of alcohol consumed and the pattern of drinking. Alcohol 
is considered as “if it were a medication” with frequent and regular 
dosing to prevent the onset rather than to treat the appearance of 
withdrawal symptoms. This proactive elimination of symptoms 
is considered fundamental from a biological perspective, since it 
protects against acute brain dysregulation, which, in turn, might 
sensitize the brain, leading to an exaggeration of the negative 
impact associated with the disturbance of the brain homeostatic 
system. From a psychological perspective, it empowers the 
individual by restoring some control over decision-making and 
reducing the impulsivity associated with the experience and 
avoidance of cravings and withdrawal symptoms. Furthermore, 
partial controlled drinking provides a relatively stable environment 
for the individual—and their social group–to begin implementing 
lifestyle changes that lead to an increased sense of self-efficacy. This 
is considered the final mediating factor in social learning theory 
and cognitive behavioral treatment models (131).
The aim is to avoid substantial and dramatic reductions to 
the amount of alcohol consumed, which not only will prove 
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unsustainable but might also lead to the precipitation of 
withdrawal symptoms, which could be life threatening. Thus, 
small sustainable changes are implemented, and once stability 
is achieved, a further gradual reduction of alcohol intake 
can be safely undertaken. In our experience, about half of the 
patients following this approach will be able to come off alcohol 
without the use of detoxification medication (12). This model 
of detoxification is called “guided self-detox”, and alcohol is 
regarded as if it was a medication that is gradually discontinued.
Early Introduction of Lifestyle Changes
The stabilization of drinking provides for a short period a relatively 
stable and safe environment for the patient, the immediate family, 
and the patient’s social network to develop and test out lifestyle 
changes. Such early and gradual changes implemented within the 
individual’s lifestyle are necessary to provide (i) a routine in everyday 
life that will protect against early relapse, (ii) a response to the void 
that alcohol detoxification would otherwise leave in its wake, (iii) a 
distraction strategy against the onset of craving, (iv) an enhancement 
of personal responsibility, (v) a de-mystification of alcohol and a 
challenge to the omnipotence of cravings or withdrawal symptoms, 
and, finally, (vi)  protection against the acute sense of stress 
experienced in the early days of abstinence.
The involvement of family members and the immediate 
social support system in treatment helps in reframing the 
environment, modifying unrealistic expectations, and supports 
the gradual adaptation to the new family dynamics (following 
the removal of alcohol). It will help in managing the anxiety 
and difficult feelings/emotions associated with broken trust 
and promotes a partnership approach. Fundamentally, recovery 
is easier to achieve and more sustainable within a respectful, 
stress-free, and supportive environment. It is far easier for the 
patient to maintain abstinence (in particular during the first 
few weeks) within a family environment that is also abstinent, 
thus removing proximal cues/triggers (smell or sight of alcohol) 
as well more distant cues, such as elevated levels of stress or 
negative emotional states.
CONCLUSION
In this review, we have described how alcohol detoxification is a 
neurobiologically challenging time for the brain and is associated 
with cognitive impairments that contribute to the high risk of 
relapse. Despite their limitations, animal models have demonstrated 
that alcohol withdrawals induce impairments in learning, cognitive 
flexibility, memory, sociability, increased levels of anxiety, and 
disrupting sleep. The evidence is mixed on the duration of these 
effects, suggesting that, potentially, in addition to the acute effects, 
there might be long-lasting impairments. Furthermore, repeated 
withdrawals may affect some areas of cognition such as plasticity but 
not all. Evidence supports roles for elevated levels of corticosterone 
or increased expression of NMDA receptors in neuro-adaptations 
underpinning alcohol withdrawal.
How does this evidence translate into human patients? There 
is evidence that with repeated detoxifications, withdrawal seizures, 
levels of anxiety, and experience of cravings increase, whereas 
inhibitory control of certain behaviors such as reward seeking, 
cognitive flexibility, and recognition of emotions in others is reduced. 
Furthermore, attentional bias towards alcohol-associated stimuli is 
increased and predicts relapse rates and poorer treatment outcomes.
The evidence from neuroimaging studies is unable to clarify 
whether any differences observed reflect the neurotoxicity or 
neuro-adaptations from alcohol directly or predate alcohol 
consumption and increase the risk of an alcohol use disorder. 
Nevertheless, it seems that current clinical treatment with 
benzodiazepines may not be optimal in attenuating the 
hyperglutamatergic state of alcohol withdrawal.
How could the above evidence guide our clinical practice? 
The evidence reviewed in this paper suggests that the process of 
detoxification from alcohol in humans seems to have a negative 
impact on cognitive functioning and create or worsen mood 
dysregulation. These effects are temporal, although the exact 
duration is not specific as multiple factors might have an effect 
beyond and above the severity of the baseline alcohol intake 
(chronicity, amount, and pattern). Nevertheless, given that this 
impact is anticipated, it is prudent to be prepared and proactive 
into managing the associated risks. To that effect, stabilization of the 
amount and pattern of drinking, empowerment of the individual 
patient and the immediate environment to prepare and implement 
lifestyle changes in advance of stopping alcohol, and furthermore 
the avoidance, if possible, of detoxification by a gradual withdrawal 
might prevent or provide protection against or increase the ability 
of the patient and the immediate environment to cope with them.
There is some evidence that people who had more than two 
detoxifications do worse than those who had less than two 
detoxifications. Although some of the cognitive impairment 
observed might be pre-existing (i.e., as part of increasing 
vulnerability to addiction), this evidence indicates that there 
might be an accumulating effect with worsening of outcomes and 
reduction of the possibility of achieving sustainable outcomes. 
If this evidence is correct and the hypotheses that repeated 
detoxifications have a long-term negative impact, then it is 
crucial to avoid repetition of detoxifications and approach each 
detox as if it would be the last one. A proactive approach within 
the spirit of pre-habilitation to maximize the chances of lifelong 
abstinence following detoxification is even more relevant.
Further, evidence presented suggests that the medication used 
at the moment does not protect from or necessarily reverse the 
negative cognitive impact and therefore is not optimal to reduce 
the risk of relapse and possible long-term accumulative negative 
effects of detoxifications. Until such medication is developed, active 
participation with aftercare interventions to maintain abstinence 
or at least keep drinking at low risk level is crucial and every effort 
should be made for patients to continue their treatment beyond the 
end of detoxification. A pre-habilitation approach that exposes and 
familiarizes patients to psychosocial interventions will enhance their 
ability to participate in aftercare interventions.
There are several clinical questions for which we require 
evidence. How many detoxifications should we offer within a 
specific period of time? How soon after a relapse should we offer 
another detoxification? Is there a washout period following a 
detoxification or are these effects permanent? Does this mean that, 
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following two failed detoxifications, there is no further negative 
impact and therefore detoxification should be offered at any given 
opportunity? Given the above clinical uncertainties and the potential 
risks indicated by the reviewed evidence and until further evidence 
provides answers, a new treatment paradigm based on the principles 
of pre-habilitation in addition to rehabilitation seems to have major 
advantages in providing aspects of the rehabilitation treatment 
before detoxification. SPADe provides such a model, in which a 
structured Cognitive Behavior Therapy-based intervention, which 
aims to stabilize drinking, introduce early lifestyle changes, and 
involve immediate social system into proactive changes to support 
the early stages of abstinence, is consistent with pre-habilitation 
and is supported by preliminary evidence that might be effective 
(11, 12). It is important though to remind ourselves that one of 
the primary objectives of a pre-habilitation treatment paradigm is the 
empowerment of the person with the drinking problem and for the 
immediate social environment to take responsibility for the problem 
and be active agents of the solution. Structured interventions prior to 
detoxification should be offered within the spirit of pre-habilitation 
and not as a screening process to manage the ever-reducing budgets 
for inpatient detoxification as suggested in the most recent report of 
PHE (10). If implemented to screen patients, then such a use of pre-
detoxification groups could create barriers into accessing treatment 
and compromise rather than enhance long-term treatment 
outcomes (10).
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